Lack of Disclosure of “Placebo” Ingredients in Clinical Trials

There are lots of ways to manipulate clinical trials.  One way is to not use a true placebo: “When the FDA issued its approval of Merck’s BLA for Gardasil on June 8, 2006, its decision was based on a review of Merck’s data from five separate clinical trials, each of which included efficacy and safety … Continue reading Lack of Disclosure of “Placebo” Ingredients in Clinical Trials